Search - tctmd.com

Displaying 261 - 280 of 504

Sort: Relevancy | Date

News Conference News ESC 2022

No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE

Shelley Wood

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Shelley Wood

July 15, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

News Features

Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight

Yael L. Maxwell

June 16, 2022

Presentation TVT 2022

Design and Rationale of the CORCINCH-HF Pivotal Study

Presenter: Ulrich Jorde

June 09, 2022

Presentation TVT 2022

12-Month Outcomes for the AccuCinch System in HFrEF

Presenter: Nadira Hamid

June 09, 2022

Presentation TVT 2022

From Access to Anchors: The AccuCinch Ventricular Restoration System

Presenter: Azeem Latib

June 09, 2022

Presentation TVT 2022

Reverse Remodeling in Heart Failure

Presenter: Daniel Burkhoff

June 09, 2022

News Daily News

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

Todd Neale

June 09, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

Advertisement

No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE

What’s Going to Be Hot at ESC 2022?

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

TCTMD’s Top 10 Most Popular Stories for July 2022

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

TCTMD’s Top 10 Most Popular Stories for June 2022

July 2022 News Roundup

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight

Design and Rationale of the CORCINCH-HF Pivotal Study

12-Month Outcomes for the AccuCinch System in HFrEF

From Access to Anchors: The AccuCinch Ventricular Restoration System

Reverse Remodeling in Heart Failure

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

June 2022 News Roundup

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content